Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US ```json { "@context": "https://schema.org", "@type": "Article", "headline": "Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US", "description": "Moderna shares rocketed $8.21 to $67.88 today, leading the broader market, after the company unveiled a new cell therapy program and built on a wave of regulatory momentum for its mRNA platform.", "image": [ "https://assets.simplefx.com/cms/f4698acb-f4af-47e2-af1b-6f9c7856194f.jpg" ], "datePublished": "2026-07-02T09:33:45.595Z", "dateModified": "2026-07-02T09:33:45.419Z", "author": { "@type": "Organization", "name": "SimpleFX", "url": "https://simplefx.com", "sameAs": [ "https://simplefx.com/social/x", "https://simplefx.com/social/linkedin", "https://github.com/SimpleFXcom/simplefx-api", "https://simplefx.com/social/facebook", "https://simplefx.com/social/youtube", "https://simplefx.com/social/telegram", "https://simplefx.com/social/tiktok", "https://www.trustpilot.com/review/simplefx.com" ] }, "publisher": { "@type": "Organization", "name": "SimpleFX", "logo": { "@type": "ImageObject", "url": "https://simplefx.com/assets/images/simplefx-logo.png", "width": 600, "height": 60 }, "url": "https://simplefx.com", "sameAs": [ "https://simplefx.com/social/x", "https://simplefx.com/social/linkedin", "https://github.com/SimpleFXcom/simplefx-api", "https://simplefx.com/social/facebook", "https://simplefx.com/social/youtube", "https://simplefx.com/social/telegram", "https://simplefx.com/social/tiktok", "https://www.trustpilot.com/review/simplefx.com" ] }, "mainEntityOfPage": { "@type": "WebPage", "@id": "https://simplefx.com/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us" }, "articleSection": "Pendidikan Perdagangan", "keywords": "mrna.us, moderna, stocks, biotech, mrna, fda, cell-therapy, volatility", "inLanguage": "my", "isAccessibleForFree": true, "wordCount": 574, "timeRequired": "PT3M" } ``` 78% daripada akaun pelabur runcit mengalami kerugian tunai akibat daripada berdagang CFD dengan pembekal CFD ini. CFD adalah instrumen yang kompleks dan membawa risiko tinggi kehilangan wang dengan cepat disebabkan oleh leverage. 78% daripada akaun pelabur runcit kehilangan wang apabila berdagang CFD dengan penyedia ini. Anda harus mempertimbangkan sama ada anda memahami cara CFD berfungsi dan sama ada anda mampu untuk mengambil risiko tinggi kehilangan wang anda. CFD adalah instrumen yang kompleks dan membawa risiko tinggi kehilangan wang dengan cepat disebabkan oleh leverage. 78% daripada akaun pelabur runcit kehilangan wang apabila berdagang CFD dengan penyedia ini. Anda harus mempertimbangkan sama ada anda memahami cara CFD berfungsi dan sama ada anda mampu untuk mengambil risiko tinggi kehilangan wang anda. [![SimpleFX logo](./assets/images/simplefx-logo.png?v=2)](my/) Tawaran [Promosi baru Lihat tawaran bonus terkini](my/promotions "Lihat tawaran bonus terkini") [Kripto Lihat Bitcoin dan altcoin di SimpleFX](my/offer/crypto "Lihat Bitcoin dan altcoin di SimpleFX") [Forex Pilih pasangan mata wang major dan minor](my/offer/forex "Pilih pasangan mata wang major dan minor") [Indeks Terlibat dengan indeks seluruh dunia](my/offer/indices "Terlibat dengan indeks seluruh dunia") [Komoditi Pilih antara tenaga dan aset pertanian](my/offer/commodities "Pilih antara tenaga dan aset pertanian") [logam Gali pasaran bernilai tinggi](my/offer/metals "Gali pasaran bernilai tinggi") [Ekuiti Terokai syarikat Amerika, Eropah dan Asia](my/offer/equities "Terokai syarikat Amerika, Eropah dan Asia") [Earn - Stake & Trade Buat wang tambahan daripada pertaruhan dan perdagangan](my/earn-stake-trade "Buat wang tambahan daripada pertaruhan dan perdagangan") [Pergi untuk menawarkan](my/offer) Maklumat dagangan [Simbol kita Berdagang berbilang aset kewangan](my/instruments "Berdagang berbilang aset kewangan") [Cara bayaran Pelbagai pilihan fiat dan crypto](my/payments "Pelbagai pilihan fiat dan crypto") [SFX Coin Terokai pelbagai kemungkinan yang tersedia dengan token kami](my/sfx-simplefx-coin "Terokai pelbagai kemungkinan yang tersedia dengan token kami") [Bitcoin Lightning Network Capai tahap baharu dalam perdagangan kripto](my/bitcoin-lightning-network "Capai tahap baharu dalam perdagangan kripto") [Berita perdagangan Analisis pasaran harian dan kemas kini berita](my/trading-news "Analisis pasaran harian dan kemas kini berita") [Sifar yuran Terokai ciri percuma kami](my/zero-fees "Terokai ciri percuma kami") Platform [Apl mudah alih Berdagang di mana-mana sahaja anda pergi](my/mobile-app "Berdagang di mana-mana sahaja anda pergi") [Apl desktop Gunakan seluruh kuasa SimpleFX](my/desktop-app "Gunakan seluruh kuasa SimpleFX") [Apl web Gunakan teknologi canggih](my/web-trader "Gunakan teknologi canggih") [Pergi ke platform](my/platforms) [![](./assets/header/timi-logo.png) TiMi AI](my/timi-ai-trade-mate) Syarikat [Mengenai SimpleFX Semak perkara penting tentang jenama kami](my/about "Semak perkara penting tentang jenama kami") [Kesedaran keselamatan siber Ketahui cara kami melindungi transaksi anda](my/cybersecurity-awareness "Ketahui cara kami melindungi transaksi anda") [Sambung untuk perniagaan Terokai penyelesaian yang disesuaikan khusus untuk perniagaan anda](my/connect-for-business "Terokai penyelesaian yang disesuaikan khusus untuk perniagaan anda") [Pusat bantuan](my/help-center) Carian popular [ BRENT](my/instruments/BRENT)[ BTCUSD](my/instruments/BTCUSD)[ DE40](my/instruments/DE40)[ ETHUSD](my/instruments/ETHUSD)[ EURUSD](my/instruments/EURUSD)[ INTC.US](my/instruments/INTC.US)[ MSTR.US](my/instruments/MSTR.US)[ MU.US](my/instruments/MU.US)[ NATGAS](my/instruments/NATGAS)[ NVDA.US](my/instruments/NVDA.US)[ OIL](my/instruments/OIL)[ SPCX.US](my/instruments/SPCX.US)[ TSLA.US](my/instruments/TSLA.US)[ US100](my/instruments/US100)[ US500](my/instruments/US500)[ USDJPY](my/instruments/USDJPY)[ XAGUSD](my/instruments/XAGUSD)[ XAUUSD](my/instruments/XAUUSD) [Daftar](https://app.simplefx.com/signup) [Log masuk](https://app.simplefx.com/login) [Daftar](https://app.simplefx.com/signup) MY [EN - English](/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [AR - العربية](/ar/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [ES - Español](/es/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [FR - Français](/fr/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [HI - Hindi](/hi/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [ID - Bahasa Indonesia](/id/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [KO - Korean](/ko/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [MY - Malay](/my/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [PT-BR - Português](/pt/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [RU - Русский](/ru/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [TH - ภาษาไทย](/th/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [TR - Türkçe](/tr/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [VI - Tiếng Việt](/vi/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [ZH - 中文](/zh/trading-news/moderna-surges-1376-as-cell-therapy-reveal-and-fda-momentum-ignite-mrna-us) [Log masuk](https://app.simplefx.com/login) [Daftarlah sekarang](https://app.simplefx.com/signup) Tawaran [Promosi baru Lihat tawaran bonus terkini](my/promotions "Lihat tawaran bonus terkini") [Kripto Lihat Bitcoin dan altcoin di SimpleFX](my/offer/crypto "Lihat Bitcoin dan altcoin di SimpleFX") [Forex Pilih pasangan mata wang major dan minor](my/offer/forex "Pilih pasangan mata wang major dan minor") [Indeks Terlibat dengan indeks seluruh dunia](my/offer/indices "Terlibat dengan indeks seluruh dunia") [Komoditi Pilih antara tenaga dan aset pertanian](my/offer/commodities "Pilih antara tenaga dan aset pertanian") [logam Gali pasaran bernilai tinggi](my/offer/metals "Gali pasaran bernilai tinggi") [Ekuiti Terokai syarikat Amerika, Eropah dan Asia](my/offer/equities "Terokai syarikat Amerika, Eropah dan Asia") [Earn - Stake & Trade Buat wang tambahan daripada pertaruhan dan perdagangan](my/earn-stake-trade "Buat wang tambahan daripada pertaruhan dan perdagangan") [Pergi untuk menawarkan](my/offer) Maklumat dagangan [Simbol kita Berdagang berbilang aset kewangan](my/instruments "Berdagang berbilang aset kewangan") [Cara bayaran Pelbagai pilihan fiat dan crypto](my/payments "Pelbagai pilihan fiat dan crypto") [SFX Coin Terokai pelbagai kemungkinan yang tersedia dengan token kami](my/sfx-simplefx-coin "Terokai pelbagai kemungkinan yang tersedia dengan token kami") [Bitcoin Lightning Network Capai tahap baharu dalam perdagangan kripto](my/bitcoin-lightning-network "Capai tahap baharu dalam perdagangan kripto") [Berita perdagangan Analisis pasaran harian dan kemas kini berita](my/trading-news "Analisis pasaran harian dan kemas kini berita") [Sifar yuran Terokai ciri percuma kami](my/zero-fees "Terokai ciri percuma kami") Platform [Apl mudah alih Berdagang di mana-mana sahaja anda pergi](my/mobile-app "Berdagang di mana-mana sahaja anda pergi") [Apl desktop Gunakan seluruh kuasa SimpleFX](my/desktop-app "Gunakan seluruh kuasa SimpleFX") [Apl web Gunakan teknologi canggih](my/web-trader "Gunakan teknologi canggih") [Pergi ke platform](my/platforms) [![](./assets/header/timi-logo.png) TiMi AI](my/timi-ai-trade-mate) Syarikat [Mengenai SimpleFX Semak perkara penting tentang jenama kami](my/about "Semak perkara penting tentang jenama kami") [Kesedaran keselamatan siber Ketahui cara kami melindungi transaksi anda](my/cybersecurity-awareness "Ketahui cara kami melindungi transaksi anda") [Sambung untuk perniagaan Terokai penyelesaian yang disesuaikan khusus untuk perniagaan anda](my/connect-for-business "Terokai penyelesaian yang disesuaikan khusus untuk perniagaan anda") [Pusat bantuan](my/help-center) EN - English AR - العربية ES - Español FR - Français HI - Hindi ID - Bahasa Indonesia KO - Korean MY - Malay PT-BR - Português RU - Русский TH - ภาษาไทย TR - Türkçe VI - Tiếng Việt ZH - 中文 * [](my/ "Rumah") * [Berita perdagangan](my/trading-news) * Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US ============================================================================ Moderna shares rocketed $8.21 to $67.88 today, leading the broader market, after the company unveiled a new cell therapy program and built on a wave of regulatory momentum for its mRNA platform. Updated 16:05:11 26/06/2026 ![Moderna Surges 13.76% as Cell Therapy Reveal and FDA Momentum Ignite MRNA.US](https://assets.simplefx.com/cms/medium_f4698acb-f4af-47e2-af1b-6f9c7856194f.jpg) MRNA.US Explodes Higher, Tops the Index --------------------------------------- Moderna shares surged 13.76% on June 26, 2026, adding $8.21 to reach $67.88 — a move that placed the stock at the front of the broader equity market. The single-session gain extends an already aggressive run: over the past month, the stock has climbed 44.43%, swinging between a low of $43.86 and a high of $69.23. The six-month picture is even more striking, with a gain of 119.68% off a low of $29.02. Over the trailing twelve months, MRNA.US has advanced 151.54%, with a 52-week low of $22.24 and a 52-week high of $67.58. Cell Therapy Reveal and FDA Backing Drive the Breakout ------------------------------------------------------ Analysis suggests today's move was driven by two converging catalysts. First, Moderna unveiled a new cell therapy program at its Science Day event, with the company highlighting the expanding potential of its mRNA platform across multiple modalities. According to finance.yahoo.com, the Science Day provided a broad overview of research and early development programs, including validation of a T-cell engager modality with mRNA-2808 in multiple myeloma, supporting rapid advancement of a second T-cell engager, mRNA-2151, in ovarian cancer. The company also introduced an in vivo CAR-T modality with mRNA-6007 moving into early development for autoimmune diseases. Market drivers include the company's stated strategic direction toward becoming a diversified, multi-modality biotechnology company managing multiple commercial franchises. Second, investor confidence was reinforced by recent unanimous FDA advisory panel support for mFlusiva, Moderna's mRNA-based flu shot. Finance.yahoo.com reported that the FDA's Vaccines and Related Biological Products Advisory Committee unanimously backed mFlusiva for adults 50 and older, after phase 3 data showed it to be about 27% more effective than a standard flu vaccine. Analysis suggests this endorsement positions the mRNA platform for a potential second major commercial use beyond COVID-19. Fool.com noted the stock has already doubled this year and is still racing toward a major catalyst. Historical Highs in Sight as Momentum Builds -------------------------------------------- The one-month high of $69.23 represents the nearest overhead reference point visible in the historical data. On the downside, the one-month low of $43.86 and the six-month low of $29.02 mark the range from which the current rally has been constructed. The 151.54% gain over the trailing twelve months, off a low of $22.24, underscores the scale of the recovery. The pipeline of upcoming regulatory and clinical milestones — including the potential commercial trajectory of mFlusiva and the early-stage cell therapy programs — represents the next set of fundamental inflection points that analysis suggests the market will be watching closely. ### Risk Factors * High volatility after a 13.76% single-session move increases risk of sharp mean-reversion. * Clinical-stage programs including mRNA-2808, mRNA-2151, and mRNA-6007 carry inherent development and regulatory failure risk. * FDA advisory panel support for mFlusiva does not guarantee full regulatory approval; final agency decisions remain pending. * The stock has gained 119.68% over six months, raising the risk that near-term expectations are already priced in. * Concentration risk remains if the mRNA platform fails to achieve commercial diversification beyond COVID-19 as anticipated. * Broader market or sector-wide sentiment shifts could amplify downside given the elevated valuation implied by the 151.54% one-year gain. This article is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Investors should conduct their own due diligence before making any investment decisions. Price data retrieved as of 2026-06-26T16:01:05.693Z and may not reflect real-time market conditions. SimpleFX Markets Desk — real-time price movement analysis for active traders #### Bersedia untuk mula melabur? Daftar untuk SimpleFX [Daftarlah sekarang](https://app.simplefx.com/signup) Atau daftar dengan × Pembukaan akaun mudah. Cara mudah untuk mula melabur. Tiada yuran dan tiada deposit minimum Masukkan emel anda Saya menerima [Syarat Penggunaan](https://simplefx.com/legal-documents) & [Dasar Privasi](https://simplefx.com/privacy-policy/) . Buka akaun sekarang ![Temui SimpleFX](/assets/images/new-sfx-app-webtrader-mobile-v2@2x.png) ![SimpleFX](assets/images/simplefx-logo-white.png) Cari kami di [](/social/facebook)[](/social/linkedin)[](/social/youtube)[](/social/tiktok)[](/social/telegram) Sertai komuniti kami [](/social/x)[](/social/discord) Muat turun SimpleFX [](https://simplefx.com/get-app/ios) Imbas kod QR ini muat turun aplikasi. ![](https://api.simplefx.com/mobile-store/qr/ios) [](https://simplefx.com/get-app/android) Imbas kod QR ini muat turun aplikasi. ![](https://api.simplefx.com/mobile-store/qr/android) [Tawaran](my/offer) Tawaran [Kripto](my/offer/crypto) [Forex](my/offer/forex) [Indeks](my/offer/indices) [Komoditi](my/offer/commodities) [Ekuiti](my/offer/equities) [logam](my/offer/metals) [Earn - Stake & Trade](my/earn-stake-trade) [Promosi](my/promotions) [TiMi - Rakan Dagangan AI](my/timi-ai-trade-mate) [Pergi untuk menawarkan](my/offer) [Platform](my/platforms) Platform [Apl mudah alih](my/mobile-app) [Apl desktop](my/desktop-app) [Apl web](my/web-trader) [Pergi ke platform](my/platforms) Maklumat dagangan [Simbol kita](my/instruments) [Cara bayaran](my/payments) [SFX - SimpleFX Coin](my/sfx-simplefx-coin) [Bitcoin Lightning Network](my/bitcoin-lightning-network) [Sifar yuran](my/zero-fees) [API](https://github.com/SimpleFXcom/simplefx-api) [Berita perdagangan](my/trading-news) Sokongan [Pusat bantuan](my/help-center) [Soalan lazim](my/faq) [Status](my/status) [Kalkulator mata wang](my/currency-calculator) Akademi [Pendidikan](my/education) [Glosari perdagangan](my/trading-glossary) Syarikat [Tentang kita](my/about) [Kesedaran keselamatan siber](my/cybersecurity-awareness) [Sambung untuk perniagaan](my/connect-for-business) [Aset jenama](my/brand-assets) ahli gabungan [Menjadi rakan kongsi](my/affiliate) [Unilink](my/unilink) Privasi dan Peraturan [Dokumen undang-undang](my/legal-documents) [Bergolek](my/rollover) [Dasar privasi](my/privacy-policy) [Dasar kuki](https://simplefx.com/resources/SimpleFX_CookiesPolicy.pdf) **Kumpulan SimpleFX** terdiri daripada entiti berikut: **8TECH LTD** diberi kuasa dan diawasi oleh Suruhanjaya Perkhidmatan Kewangan di Mauritius nombor lesen GB23201604. Alamat Pejabat: 18 Bank Street Ground Floor, Silver Bank Tower Cybercity, Ebene, Mauritius. 8TECH LTD tidak menyediakan sebarang Perkhidmatan Pertukaran Fiat atau perkhidmatan pertukaran Cryptocurrency. 8TECH LTD tidak menyokong akaun dagangan mata wang kripto mahupun deposit mata wang kripto. **8TECH ZA (PTY) LTD** Pembekal Perkhidmatan Aset Kripto dan FSP dengan No Lesen 53073 Diberi Kuasa oleh Pihak Berkuasa Kelakuan Sektor Kewangan (FSCA), Alamat pejabat: 4 Haven Lane Malvern Queensburgh Durban Kwa-Zulu Natal 4093, Afrika Selatan. 8TECH ZA (PTY) LTD menawarkan deposit mata wang kripto dan menyokong akaun dagangan mata wang kripto berdasarkan lesen FSCA No 53073 dengan subkategori aset kripto. **8TECH PA LLC** dilesenkan oleh Pihak Berkuasa Perkhidmatan Antarabangsa Kuna de Wargandí (KUNAISA) di bawah Lesen FOREX No. FX0032026 dan Lesen VASP No. V0042026, dengan nombor syarikat 0004-IBC-2026 dan alamat berdaftarnya di Central Street, Kunaisa Bldg., Nurrá-Wala-Mortí, Wilayah Kuna de Wargandí, Republik Panama. 8TECH PA LLC ialah pemilik laman web SimpleFX: Platform perdagangan & pelaburan percuma. **Kumpulan SimpleFX** tidak dibenarkan oleh mana-mana pihak berkuasa EU, Pihak Berkuasa Kompeten Kebangsaan EEA atau United Kingdom. Perkhidmatan SimpleFX berada di luar rangka kerja kawal selia EU dan UK. Anda tidak akan dilindungi oleh Dana Pampasan Pelabur. Maklumat di laman web ini tidak membentuk, dan juga tidak boleh ditafsirkan atau difahami sebagai dorongan atau permintaan untuk melibatkan diri dalam sebarang aktiviti pelaburan atau perdagangan dan tidak bertujuan sebagai pemasaran atau promosi perkhidmatan SimpleFX kepada warga EU, EEA atau UK. **Kumpulan SimpleFX** tidak menyediakan perkhidmatan kepada rakyat dan penduduk Amerika Syarikat atau mana-mana negara di mana pengedaran atau penggunaan sedemikian akan bertentangan dengan undang-undang atau peraturan tempatan. **AMARAN RISIKO** Dagangan margin dalam mata wang asing, aset maya atau produk luar pertukaran lain pada margin membawa tahap risiko yang tinggi dan mungkin tidak sesuai untuk semua orang. Kami menasihati anda untuk mempertimbangkan dengan teliti sama ada dagangan sesuai untuk anda berdasarkan keadaan peribadi anda. CFD adalah instrumen yang kompleks dan membawa risiko tinggi kehilangan wang dengan cepat disebabkan oleh leverage. 78% daripada akaun pelabur runcit kehilangan wang apabila berdagang CFD dengan penyedia ini. Anda harus mempertimbangkan sama ada anda memahami cara CFD berfungsi dan sama ada anda mampu untuk mengambil risiko tinggi kehilangan wang anda. Cukai mungkin perlu dibayar ke atas sebarang keuntungan dan anda harus mendapatkan nasihat bebas mengenai kedudukan percukaian anda. 2026 SimpleFX. Hak cipta terpelihara. [ Tulis kepada kami. Kami membalas 24/5. ](https://app.simplefx.com/login?action=open-livechat)